EP3008168A4
(en )
2017-05-31
Sc- cells and compositions and methods for generating the same
EP3043824A4
(en )
2017-10-25
Modified therapeutic agents and compositions thereof
EP4230264A3
(en )
2024-03-06
Prodrugs of fumarates and their use in treating various deseases
EP3030266A4
(en )
2017-03-15
Topical compositions and methods of using the same
EP3049429A4
(en )
2017-08-02
Compositions and methods utilizing lysophosphatidylcholine scaffolds
EP3019166A4
(en )
2017-04-19
A pharmaceutical combination for the treatment of melanoma
EP3057597B8
(en )
2019-08-14
Anti-inflammatory phytonutrients for use in the treatment or prevention of synovitis
EP2866830A4
(en )
2015-12-09
ANTI-CXCL9, ANTI-CXCL10, ANTI-CXCL11, ANTI-CXCL13, ANTI-CXCR3 AND ANTI-CXCR5 AGENTS FOR THE INHIBITION OF INFLAMMATION
EP2992334A4
(en )
2017-04-19
Novel phosphatidylalkanols and compositions thereof
CA2875305C
(en )
2021-06-01
Fbxo3 inhibitors
EP3035817A4
(en )
2017-01-25
Clasp
EP2906361A4
(en )
2016-09-14
COATING COMPOSITIONS AND METHODS OF MANUFACTURING THE SAME
EP3021848A4
(en )
2017-02-08
Treatment for melanoma
HK1205174A1
(en )
2015-12-11
Uv-curable coating compositions and methods for using the same
PH12016500497A1
(en )
2016-06-13
Compositions for the treatment of hypertension and/or fibrosis
EP3071534A4
(en )
2017-06-28
Fertiliser composition
EP3065829A4
(en )
2017-07-05
Compositions and methods for treating melanoma
EP3038631A4
(en )
2017-03-29
Anti-inflammatory compositions, methods and uses thereof
EP3007704A4
(en )
2017-03-15
Combination therapy
EP3049982A4
(en )
2017-05-03
Revocable platform identifiers
UA117567C2
(uk )
2018-08-27
Композиція, яка стимулює лактацію, на основі фосфатидилсерину
EP3074049A4
(en )
2017-05-17
Novel cell-penetrating compositions and methods using same
EP3068431A4
(en )
2017-08-23
Methods and compositions for the treatment of hcmv
EP3747444A3
(en )
2021-03-10
Use of sedoheptulose as a nutritional supplement
EP3063170A4
(en )
2017-06-28
Compositions and methods for increasing the half-life of factor xa